Market open · Delayed intraday data · 10:15 AM ET
Last update: Nov 18, 2026, 10:08 AM ET

Trending Tickers

The stocks moving most, ranked by their latest session change — across all 986 companies we track. Click any ticker for the full change report.

986 stocks tracked
Most Active This Week
LQDA
Liquidia Corporation
$56.73▲ 0.64%
— · —
ValuationWhat changed:

Liquidia rallied 4.29% to $57.58 following a wave of analyst upgrades anchored by Raymond James' upgrade to Strong Buy with a $77 price target (raised from $53) and BTIG's hike to $87 (from $70), both citing robust Q3 results and resilient demand. Q3 revenues surged 314.9% year-over-year to $225.3M, driven by YUTREPIA pulmonary arterial hypertension drug sales of $222.7M, per Zacks earnings coverage. Volume of 523K shares remains below the 0.59x time-adjusted average.

🐂 Bullish — Score 60/100
View Full Report →
30D High
$56.73
30D Low
$33.94
30D Change
+67.15%
Risk Level
High

Most Significant Changes

Ranked by largest 1-day move

1
PSKYParamount Skydance Corporation Class B Common Stock
$9.77▲ 41.39%30D: +38.39%
High: $9.77Low: $6.91Risk: High
45 changes
No changes detected this week
2
NXTNextpower Inc.
$78.48▼ 12.13%30D: -4.94%
High: $89.31Low: $78.48Risk: High
65 changes
RiskNextpower Inc. (NXT) fell 6.70% to $83.33 intraday following a Capital Markets Day event (Business Wire). The decline occurred on volume 1.45x the time-adjusted average, suggesting coordinated selling rather than thin liquidity.1d ago
3
ACMAecom
$80.53▲ 11.08%30D: +38.01%
High: $80.53Low: $58.35Risk: Low
37 changes
ActivityAecom filed an 8-K material event disclosure and earnings report today, triggering a 9.43% intraday rally to $79.33. Volume surged to 3.29x the time-adjusted average (988,187 shares in 90 minutes), signaling strong institutional interest. The specific content of the 8-K and earnings details are not yet public in available sources, but the dual filing suggests a significant corporate development or beat.1d ago
4
SMMTSummit Therapeutics Inc.
$10.67▼ 9.73%30D: -29.48%
High: $15.13Low: $10.67Risk: High
65 changes
RiskSummit Therapeutics filed a material event (8-K) today, triggering a 9.21% intraday decline to $10.73. The specific details of the filing were not disclosed in available sources, but the timing coincides with elevated volume at 2.11x the session average, suggesting market reaction to a material announcement from the company.1d ago
5
CRMSalesforce, Inc.
$194.52▼ 9.45%30D: -17.56%
High: $235.95Low: $194.52Risk: High
61 changes
ValuationSalesforce fell 9.46% to $194.50, driven by a confluence of AI monetization skepticism, sector-wide SaaS rotation, and balance-sheet concerns tied to recent M&A including the $5.7 billion Braze acquisition (per web sources). Volume surged to 2.24x the expected level 150 minutes into the session, signaling institutional selling pressure as the stock broke through key technical support.1d ago
6
RYTMRhythm Pharmaceuticals, Inc.
$116.61▲ 8.49%30D: +34.48%
High: $116.61Low: $86.71Risk: High
46 changes
Material / EarningsRhythm Pharmaceuticals, Inc. (RYTM) moved +9.49% from $106.50 to $116.61 on 2026-11-17 after presenting two-year Phase 3 TRANSCEND trial data showing setmelanotide sustained BMI reductions in acquired hypothalamic obesity. Volume was 2.8x the 5-day average.1d ago
7
SNAPSnap Inc.
$5.50▲ 8.06%30D: -9.84%
High: $6.10Low: $5.09Risk: High
56 changes
Material / EarningsSnap Inc. (SNAP) moved +7.32% from $5.12 to $5.50 on November 17, 2026. No new company-specific catalyst was announced on the move date. The rally appears to be a technical relief bounce after SNAP fell roughly 17% over the preceding month, including a 14% post-earnings decline following its November 4 Q3 report where ad growth and North American daily active users missed expectations. Trading volume on the bounce was elevated at 2.0x the 5-day average.1d ago
8
ENPHEnphase Energy, Inc.
$23.06▼ 7.58%30D: -21.43%
High: $29.35Low: $23.06Risk: High
62 changes
No changes detected this week
9
QXOQXO, Inc.
$11.11▼ 7.49%30D: +7.55%
High: $12.01Low: $10.33Risk: High
59 changes
RiskQXO declined 6.08% to $11.28 intraday with no specific catalyst identified today. Volume of 10.1M shares trades at 0.98x the historical average for this time of session, suggesting modest institutional participation in the selloff.1d ago
10
JOBYJoby Aviation, Inc.
$4.38▼ 7.20%30D: -4.99%
High: $4.72Low: $4.38Risk: High
75 changes
No changes detected this week
11
INTUIntuit Inc.
$320.79▼ 7.17%30D: +3.33%
High: $345.56Low: $310.44Risk: High
62 changes
ValuationIntuit fell 6.57% to $322.86 as the tech sector weakened following former Nvidia CEO Jensen Huang's resignation (Motley Fool, Nov. 17). The sell-off intensifies pre-earnings caution: INTU reports Q1 fiscal 2027 results on Nov. 19, and the web_catalyst notes lingering pressure from earlier workforce reductions and softness in legacy DIY tax and Mailchimp segments. Volume was 1.13x typical for this stage of the session—normal trade.1d ago
12
CGONCG Oncology Inc.
$78.94▼ 6.89%30D: +27.65%
High: $84.78Low: $61.84Risk: High
41 changes
ValuationCG Oncology announced positive Phase 3 PIVOT-006 trial results for cretostimogene in intermediate-risk and high-grade Ta non-muscle-invasive bladder cancer, with the company stating it is the first therapeutic to demonstrate significant recurrence benefit in this patient population (web catalyst). Stock surged +14.35% to $85.08 on 7.22x elevated volume, with the data triggering plans for two BLA filings in 2027.2d ago
13
HUBSHubSpot, Inc.
$216.30▼ 6.76%30D: -4.39%
High: $231.98Low: $216.30Risk: High
60 changes
No changes detected this week
14
LUMNLumen Technologies, Inc.
$4.30▲ 6.70%30D: -5.49%
High: $4.55Low: $4.03Risk: High
63 changes
No changes detected this week
15
TWSTTwist Bioscience Corporation
$112.00▲ 6.63%30D: -24.41%
High: $148.16Low: $105.04Risk: Medium
56 changes
ValuationTwist Bioscience reported Q4 FY2026 revenue of $126.6 million, beating consensus estimates of $123–124 million, and achieved a profitability milestone with adjusted EBITDA of $2.2 million (per Business Wire and Zacks). However, management's initial fiscal 2027 guidance disappointed: organic growth projected at ~21% and AI drug discovery revenue at ~$100 million (~69% growth) fell short of prior "triple-digit order growth" expectations, and gross margin guidance of 52.5–53% trailed consensus. The stock fell 10.47% to $109.75 on elevated volume of 3.93x average, triggering a "sell the news" reaction despite the revenue beat.6d ago
16
RGTIRigetti Computing, Inc.
$8.46▼ 6.62%30D: -27.57%
High: $11.68Low: $8.46Risk: High
80 changes
ValuationRigetti Computing shares fell 5.04% to $9.13, driven by a combination of disappointing third-quarter results and multiple analyst price-target cuts. The company reported Q3 revenue of $1.41 million versus $3.67 million expected, along with widening operating losses ($110 million) and negative free cash flow ($111 million) over 12 months; Mizuho, Needham, and Jefferies subsequently cut price targets to $17, $15, and $12 respectively (per Motley Fool). Volume of 10.3 million shares was 0.84x the time-adjusted expected level—normal for intraday.2d ago
17
NOWServiceNow, Inc.
$92.90▼ 6.51%30D: -33.63%
High: $139.98Low: $92.90Risk: High
77 changes
RiskServiceNow announced a surge in AI usage and raised its annual contract value target to $1.7 billion (per MarketBeat), yet shares fell 5.64% to $93.77. The disconnect suggests investors may be digesting the guidance raise against current valuation or profit-taking after a likely recent run-up; volume at 1.60x the time-adjusted average indicates moderate institutional participation in the sell-off.1d ago
18
SBACSBA Communications Corporation
$174.56▼ 6.46%30D: -3.40%
High: $186.61Low: $174.56Risk: Low
44 changes
No changes detected this week
19
MSTRStrategy Inc
$96.50▼ 6.34%30D: -32.63%
High: $143.24Low: $96.50Risk: High
90 changes
RiskStrategy Inc (MSTR) fell 3.65% to $99.27 in early trading with volume at 1.56x normal levels for this session time. No specific intraday catalyst was identified in news or filings; the decline occurred alongside typical trading activity without announcement-driven moves.1d ago
20
FIGFigma, Inc.
$18.18▼ 6.34%30D: -15.36%
High: $21.48Low: $18.18Risk: High
49 changes
No changes detected this week
21
TRUTransUnion
$76.33▼ 6.33%30D: +14.03%
High: $81.49Low: $66.94Risk: High
52 changes
No changes detected this week
22
NKENIKE, Inc.
$35.85▼ 6.30%30D: +1.56%
High: $38.26Low: $35.30Risk: High
76 changes
RiskNike shares fell 7.48% to $35.40 intraday despite positive forward guidance. The Wall Street Journal and Reuters reported Nike expects performance athleticwear to drive long-term growth and $5 billion in incremental revenue by 2031, while the company plans $12 billion in shareholder distributions via dividends. Volume surged to 51.5M shares (2.61x typical for this time of day), suggesting heavy selling pressure that overwhelmed the constructive guidance narrative.1d ago
23
ESTCElastic N.V.
$80.39▼ 6.29%30D: -12.68%
High: $92.06Low: $80.39Risk: High
46 changes
No changes detected this week
24
GWREGuidewire Software, Inc.
$145.42▼ 6.17%30D: -11.82%
High: $164.92Low: $145.42Risk: High
47 changes
No changes detected this week
25
IONQIonQ, Inc.
$24.84▼ 6.09%30D: -20.94%
High: $31.42Low: $24.84Risk: High
95 changes
ValuationIonQ fell 5.14% to $25.09 following a Seeking Alpha downgrade citing shareholder dilution concerns amid quantum progress. Volume surged to 7.3M shares, running 2.18x the typical pace for this time of day, signaling coordinated selling pressure.1d ago
26
FSLRFirst Solar, Inc.
$152.97▼ 5.84%30D: -14.58%
High: $179.08Low: $152.97Risk: High
64 changes
No changes detected this week
27
CCICrown Castle Inc.
$84.16▼ 5.82%30D: +6.02%
High: $89.36Low: $79.38Risk: Medium
45 changes
No changes detected this week
28
WDAYWorkday, Inc.
$182.80▼ 5.80%30D: -3.16%
High: $194.06Low: $182.80Risk: High
48 changes
RiskWorkday fell 4.14% to $186.02 amid pre-earnings nervousness and a broader software-sector pullback. With earnings due November 24, options markets are pricing in an expected post-earnings move of ~7%, prompting investors to trim exposure ahead of the report. Peer enterprise software names (Salesforce, Intuit, Adobe) are also trading lower as the market reassesses how autonomous AI agents and shifting IT budgets will impact legacy SaaS platform demand.1d ago
29
MDBMongoDB, Inc.
$298.63▼ 5.77%30D: -16.18%
High: $356.29Low: $298.63Risk: High
67 changes
ValuationMongoDB announced an agreement to acquire Firebolt Analytics Inc., a real-time analytics platform, to expand its Intelligent Data Platform — a move that triggered investor concerns about execution and integration risks. The stock fell 5.44% to $299.68 on the news (per FMP delayed intraday), with volume at 1.06x expected levels — normal for this time of session. The SEC 8-K filing and investor relations update confirmed the transaction details today.1d ago
30
CAVACAVA Group, Inc.
$51.98▼ 5.75%30D: +0.76%
High: $55.15Low: $51.59Risk: High
49 changes
No changes detected this week
Change Categories
Types of changes detected this week
Material / Earnings19
Activity11
Risk26

Side-by-Side Comparison

30-day snapshot across all tracked stocks

Symbol
Price
1D %
30D %
30D High
30D Low
Risk
Changes
PSKY
$9.77
▲ 41.39%
▲ 38.39%
$9.77
$6.91
High
45
NXT
$78.48
▼ 12.13%
▼ 4.94%
$89.31
$78.48
High
65
ACM
$80.53
▲ 11.08%
▲ 38.01%
$80.53
$58.35
Low
37
SMMT
$10.67
▼ 9.73%
▼ 29.48%
$15.13
$10.67
High
65
CRM
$194.52
▼ 9.45%
▼ 17.56%
$235.95
$194.52
High
61
RYTM
$116.61
▲ 8.49%
▲ 34.48%
$116.61
$86.71
High
46
SNAP
$5.50
▲ 8.06%
▼ 9.84%
$6.10
$5.09
High
56
ENPH
$23.06
▼ 7.58%
▼ 21.43%
$29.35
$23.06
High
62
QXO
$11.11
▼ 7.49%
▲ 7.55%
$12.01
$10.33
High
59
JOBY
$4.38
▼ 7.20%
▼ 4.99%
$4.72
$4.38
High
75
INTU
$320.79
▼ 7.17%
▲ 3.33%
$345.56
$310.44
High
62
CGON
$78.94
▼ 6.89%
▲ 27.65%
$84.78
$61.84
High
41
HUBS
$216.30
▼ 6.76%
▼ 4.39%
$231.98
$216.30
High
60
LUMN
$4.30
▲ 6.70%
▼ 5.49%
$4.55
$4.03
High
63
TWST
$112.00
▲ 6.63%
▼ 24.41%
$148.16
$105.04
Medium
56
RGTI
$8.46
▼ 6.62%
▼ 27.57%
$11.68
$8.46
High
80
NOW
$92.90
▼ 6.51%
▼ 33.63%
$139.98
$92.90
High
77
SBAC
$174.56
▼ 6.46%
▼ 3.40%
$186.61
$174.56
Low
44
MSTR
$96.50
▼ 6.34%
▼ 32.63%
$143.24
$96.50
High
90
FIG
$18.18
▼ 6.34%
▼ 15.36%
$21.48
$18.18
High
49
TRU
$76.33
▼ 6.33%
▲ 14.03%
$81.49
$66.94
High
52
NKE
$35.85
▼ 6.30%
▲ 1.56%
$38.26
$35.30
High
76
ESTC
$80.39
▼ 6.29%
▼ 12.68%
$92.06
$80.39
High
46
GWRE
$145.42
▼ 6.17%
▼ 11.82%
$164.92
$145.42
High
47
IONQ
$24.84
▼ 6.09%
▼ 20.94%
$31.42
$24.84
High
95
FSLR
$152.97
▼ 5.84%
▼ 14.58%
$179.08
$152.97
High
64
CCI
$84.16
▼ 5.82%
▲ 6.02%
$89.36
$79.38
Medium
45
WDAY
$182.80
▼ 5.80%
▼ 3.16%
$194.06
$182.80
High
48
MDB
$298.63
▼ 5.77%
▼ 16.18%
$356.29
$298.63
High
67
CAVA
$51.98
▼ 5.75%
▲ 0.76%
$55.15
$51.59
High
49
FICO
$676.52
▼ 5.68%
▼ 5.99%
$719.63
$676.52
High
52
HNGE
$114.41
▼ 5.67%
▲ 8.96%
$121.29
$105.00
Low
47
CHWY
$20.42
▼ 5.55%
▼ 1.97%
$21.62
$20.42
High
53
HIMS
$17.55
▼ 5.44%
▼ 36.69%
$27.72
$17.55
High
84
UNH
$389.68
▼ 5.42%
▼ 1.50%
$412.02
$389.68
Medium
73
CRCL
$54.63
▼ 5.24%
▼ 31.33%
$79.55
$54.63
High
76
AFRM
$59.44
▼ 5.21%
▼ 15.70%
$70.51
$59.44
High
71
KRMN
$35.55
▼ 5.17%
▲ 17.95%
$37.49
$30.14
High
65
MOH
$221.21
▼ 5.10%
▲ 5.75%
$233.09
$209.19
High
36
MKC
$44.73
▼ 5.09%
▼ 0.16%
$47.13
$44.73
High
31
RBRK
$100.68
▼ 5.05%
▼ 11.61%
$113.90
$100.68
High
57
Z
$28.26
▼ 5.04%
▼ 0.25%
$29.76
$28.26
High
51
PS
$43.38
▼ 5.04%
▼ 4.83%
$45.68
$43.38
High
61
ZG
$28.54
▼ 5.02%
▼ 2.49%
$30.05
$28.54
High
50
GPN
$85.32
▼ 5.01%
▲ 5.48%
$89.82
$80.89
Low
32
GDDY
$106.71
▼ 4.91%
▲ 3.24%
$112.22
$103.36
Low
59
DOCU
$75.93
▼ 4.87%
▲ 0.93%
$79.82
$75.23
High
45
EFX
$180.30
▼ 4.85%
▲ 19.91%
$189.50
$150.36
High
51
ZM
$91.52
▼ 4.85%
▼ 3.12%
$96.18
$91.52
High
49
FDS
$316.10
▼ 4.84%
▲ 9.10%
$332.17
$289.74
High
50

Recent Change Activity

All changes in the past 7 days

Material / Earnings
TGT
Target Corporation (TGT) reported EPS of $2.65 vs. consensus estimate of $2.08, beating estimates by 27.4% on 2026-11-18.
today
Valuation
FCX
Freeport-McMoRan fell 5.75% to $52.12, driven by a combination of subsidiary debt news and analyst downgrade. PT Freeport Indonesia (FCX's 48.76%-owned subsidiary) priced $750 million of senior notes due 2033 at 6.90%, raising debt refinancing concerns, while Erste Group Bank downgraded FCX from buy to hold on November 18, 2026. The decline reflects broader pressure on copper miners amid commodity price volatility.
today
Risk
AAOI
Applied Optoelectronics (AAOI) fell 8.67% to $41.30 after filing a material event 8-K with the SEC today. The specific content of the filing was not yet available in real-time snapshots, but the timing coincided with the intraday decline.
today
Activity
TJX
TJX beat Q3 earnings expectations with EPS of $1.34 vs. consensus $1.33 and raised full-year guidance, citing accelerating sales trends through the holiday season (Zacks, WSJ). The stock surged 9.50% from $129.85 to $142.18 on the news.
today
Material / Earnings
SNAP
Snap Inc. (SNAP) moved +7.32% from $5.12 to $5.50 on November 17, 2026. No new company-specific catalyst was announced on the move date. The rally appears to be a technical relief bounce after SNAP fell roughly 17% over the preceding month, including a 14% post-earnings decline following its November 4 Q3 report where ad growth and North American daily active users missed expectations. Trading volume on the bounce was elevated at 2.0x the 5-day average.
1d ago
Material / Earnings
RYTM
Rhythm Pharmaceuticals, Inc. (RYTM) moved +9.49% from $106.50 to $116.61 on 2026-11-17 after presenting two-year Phase 3 TRANSCEND trial data showing setmelanotide sustained BMI reductions in acquired hypothalamic obesity. Volume was 2.8x the 5-day average.
1d ago
Material / Earnings
NKE
NIKE, Inc. (NKE) moved -10.82% from $40.20 to $35.85 on 2026-11-17, reaching a new 30-day low on volume 3.8x the 5-day average. The sell-off came after Nike announced a $12 billion shareholder dividend distribution and projected $5 billion incremental revenue growth by 2031 as part of its 'Full Stride Ahead' growth strategy, with management emphasizing performance athleticwear as a long-term growth driver.
1d ago
Valuation
AFRM
Affirm Holdings fell 5.07% to $59.53 as a sector-wide repricing of buy-now-pay-later and fintech lenders intensified, driven by rising Treasury yields (10-year near 5.1%) that increase the company's cost of capital and pressure long-duration consumer receivables, combined with fresh analyst price-target cuts from firms like Truist Financial and lingering credit-quality concerns following Affirm's early November earnings report. Broader tech and financial sector weakness added to the selloff.
1d ago
Risk
WDAY
Workday fell 4.14% to $186.02 amid pre-earnings nervousness and a broader software-sector pullback. With earnings due November 24, options markets are pricing in an expected post-earnings move of ~7%, prompting investors to trim exposure ahead of the report. Peer enterprise software names (Salesforce, Intuit, Adobe) are also trading lower as the market reassesses how autonomous AI agents and shifting IT budgets will impact legacy SaaS platform demand.
1d ago
Risk
QXO
QXO declined 6.08% to $11.28 intraday with no specific catalyst identified today. Volume of 10.1M shares trades at 0.98x the historical average for this time of session, suggesting modest institutional participation in the selloff.
1d ago
Valuation
INTU
Intuit fell 6.57% to $322.86 as the tech sector weakened following former Nvidia CEO Jensen Huang's resignation (Motley Fool, Nov. 17). The sell-off intensifies pre-earnings caution: INTU reports Q1 fiscal 2027 results on Nov. 19, and the web_catalyst notes lingering pressure from earlier workforce reductions and softness in legacy DIY tax and Mailchimp segments. Volume was 1.13x typical for this stage of the session—normal trade.
1d ago
Risk
APP
AppLovin declined 5.40% to $392.81, driven by institutional profit-taking after a multi-week rally following strong Q3 2026 earnings in early November, combined with broader selling pressure across high-duration tech and digital advertising stocks amid fluctuating Treasury yields. Volume of 1.41M shares ran at 0.80x expected for this point in the session, consistent with normal intraday patterns.
1d ago
Activity
ACM
Aecom filed an 8-K material event disclosure and earnings report today, triggering a 9.43% intraday rally to $79.33. Volume surged to 3.29x the time-adjusted average (988,187 shares in 90 minutes), signaling strong institutional interest. The specific content of the 8-K and earnings details are not yet public in available sources, but the dual filing suggests a significant corporate development or beat.
1d ago
Risk
NXT
Nextpower Inc. (NXT) fell 6.70% to $83.33 intraday following a Capital Markets Day event (Business Wire). The decline occurred on volume 1.45x the time-adjusted average, suggesting coordinated selling rather than thin liquidity.
1d ago
Risk
MSTR
Strategy Inc (MSTR) fell 3.65% to $99.27 in early trading with volume at 1.56x normal levels for this session time. No specific intraday catalyst was identified in news or filings; the decline occurred alongside typical trading activity without announcement-driven moves.
1d ago
Valuation
MDB
MongoDB announced an agreement to acquire Firebolt Analytics Inc., a real-time analytics platform, to expand its Intelligent Data Platform — a move that triggered investor concerns about execution and integration risks. The stock fell 5.44% to $299.68 on the news (per FMP delayed intraday), with volume at 1.06x expected levels — normal for this time of session. The SEC 8-K filing and investor relations update confirmed the transaction details today.
1d ago
Risk
CRCL
Circle Internet Group (CRCL) fell 3.10% to $55.86 as of midday trading. Commonwealth Equity Services LLC acquired 11,808 shares, per defenseworld.net; volume stands at 2.14M shares (1.42x the time-adjusted expected level), indicating normal intraday activity.
1d ago
Valuation
IONQ
IonQ fell 5.14% to $25.09 following a Seeking Alpha downgrade citing shareholder dilution concerns amid quantum progress. Volume surged to 7.3M shares, running 2.18x the typical pace for this time of day, signaling coordinated selling pressure.
1d ago
Risk
NOW
ServiceNow announced a surge in AI usage and raised its annual contract value target to $1.7 billion (per MarketBeat), yet shares fell 5.64% to $93.77. The disconnect suggests investors may be digesting the guidance raise against current valuation or profit-taking after a likely recent run-up; volume at 1.60x the time-adjusted average indicates moderate institutional participation in the sell-off.
1d ago
Risk
NKE
Nike shares fell 7.48% to $35.40 intraday despite positive forward guidance. The Wall Street Journal and Reuters reported Nike expects performance athleticwear to drive long-term growth and $5 billion in incremental revenue by 2031, while the company plans $12 billion in shareholder distributions via dividends. Volume surged to 51.5M shares (2.61x typical for this time of day), suggesting heavy selling pressure that overwhelmed the constructive guidance narrative.
1d ago
Risk
CGON
CG Oncology filed a material event (8-K) today, triggering a sharp intraday decline of 7.21% from $84.78 to $78.67 according to FMP delayed data. Volume surged to 3.58× the historical average for this time of session, signaling institutional reaction to the undisclosed event.
1d ago
Risk
SMMT
Summit Therapeutics filed a material event (8-K) today, triggering a 9.21% intraday decline to $10.73. The specific details of the filing were not disclosed in available sources, but the timing coincides with elevated volume at 2.11x the session average, suggesting market reaction to a material announcement from the company.
1d ago
Valuation
CRM
Salesforce fell 9.46% to $194.50, driven by a confluence of AI monetization skepticism, sector-wide SaaS rotation, and balance-sheet concerns tied to recent M&A including the $5.7 billion Braze acquisition (per web sources). Volume surged to 2.24x the expected level 150 minutes into the session, signaling institutional selling pressure as the stock broke through key technical support.
1d ago
Material / Earnings
CGON
CG Oncology Inc. (CGON) moved -7.85% from $92.00 to $84.78 on 2026-11-16, one day after announcing positive Phase 3 PIVOT-006 trial results showing cretostimogene achieved 68% recurrence risk reduction in intermediate-risk and high-grade non-muscle-invasive bladder cancer. The stock initially rallied 14% on the news before reversing.
2d ago
Material / Earnings
POWL
Powell Industries, Inc. (POWL) reported EPS of $2.23 vs. consensus estimate of $1.57, beating by 42.0% on 2026-11-16.
2d ago
Valuation
CDE
Coeur Mining fell 6.34% to $13.09 as precious metals sector weakness pressured the stock. Spot silver prices dropped sharply toward $46.80–$47.00/oz and gold futures hit multi-month lows, driven by a stronger U.S. dollar and rising expectations for a December Fed rate hike (Fortune). The decline also reflects lingering caution from the company's Q3 earnings report released earlier in November and recent analyst target adjustments. Volume of 36.3M shares was normal for the session timing.
2d ago
Risk
FCX
Freeport-McMoRan fell 6.93% to $55.13 after subsidiary PT Freeport Indonesia announced a U.S. dollar-denominated senior notes offering to refinance existing debt, per web sources citing the filing. The decline also reflects investor concern over the company's $4.5 billion Bagdad mine expansion project and broader commodity sector weakness, with volume at 1.13x normal for the time of session.
2d ago
Risk
KTOS
Kratos Defense fell 6.30% to $31.77 intraday despite positive momentum in defense spending and the company's expansion into hypersonic technologies and advanced manufacturing, as reported by Zacks on November 16. Volume traded 0.61x expected levels at this point in the session, suggesting below-average participation in the selloff.
2d ago
Risk
CORT
Corcept Therapeutics fell 5.38% to $69.02, driven by a combination of post-earnings valuation cooldown following strong Q3 2026 results reported November 3, and competitive pressures in oncology from rival trial data (including Genmab's Phase 3 ovarian cancer therapy results in late October) that raised questions about the commercial trajectory of Corcept's newly launched Lifyorli® (relacorilant). Volume traded 496,998 shares by the 320-minute mark, approximately 0.47x the expected daily average for that time—below typical levels.
2d ago
Valuation
TWST
Twist Bioscience shares fell 5.22% to $105.78 following investor disappointment with the company's fiscal 2027 outlook, despite better-than-expected quarterly results. Multiple covering analysts subsequently lowered their price targets on the stock, adding downward pressure to the decline.
2d ago
Valuation
RGTI
Rigetti Computing shares fell 5.04% to $9.13, driven by a combination of disappointing third-quarter results and multiple analyst price-target cuts. The company reported Q3 revenue of $1.41 million versus $3.67 million expected, along with widening operating losses ($110 million) and negative free cash flow ($111 million) over 12 months; Mizuho, Needham, and Jefferies subsequently cut price targets to $17, $15, and $12 respectively (per Motley Fool). Volume of 10.3 million shares was 0.84x the time-adjusted expected level—normal for intraday.
2d ago
Risk
HIMS
Hims & Hers Health declined 4.18% to $18.91 following recent earnings that revealed a net loss despite 49% revenue growth, driven by deteriorating gross margins according to the Motley Fool (November 16). Volume of 6.8 million shares was below average for this point in the session, suggesting modest participation in the sell-off.
2d ago
Activity
POWL
Powell Industries shares rose 6.57% to $152.10 ahead of fiscal Q4 2026 earnings scheduled for release after market close today (November 16), according to Google Finance and Yahoo Finance coverage. Elevated volume of 2.62x the time-adjusted average signals active positioning by investors anticipating the results, which carry a consensus EPS estimate of $1.52 (up 7.8% year-over-year) and expected quarterly revenue around $328.35 million.
2d ago
Risk
HL
Hecla Mining declined 5.87% to $12.33 as precious metals sold off broadly on hawkish Federal Reserve signals and elevated Treasury yields following hot inflation data, according to web sources. Silver and gold miners tracked downward pressure on spot prices, with the stronger U.S. dollar reducing overseas demand for dollar-denominated commodities. Volume reached 19.7M shares (1.17x normal for this time of session), consistent with sector-wide selling.
2d ago
Valuation
ARWR
Arrowhead Pharmaceuticals extended a post-earnings sell-off that began following the company's November 12 quarterly results, which reported a loss of -$5.11 per share, well below expectations. The stock declined 4.76% to $45.50 on November 16, with volume at 0.56x the time-adjusted average, indicating below-average trading activity during the decline. The sell-off persists despite the company's November 4 announcement of a $400 million senior secured term loan refinancing with Sixth Street to lower borrowing costs.
2d ago
Risk
HOOD
Robinhood fell 7.57% to $71.97 as a crypto market selloff, regulatory headwinds, and insider selling pressured the stock. Bitcoin dropped sharply toward $64,000—its weakest level since July—triggering multi-billion-dollar ETF outflows that dampened retail trading activity on the platform. Louisiana's Attorney General filed a lawsuit targeting Robinhood's prediction markets business, a key growth segment. A Form 144 insider sale notice on November 15 compounded the selling pressure amid a broader risk-off market tone (Benzinga, defenseworld.net).
2d ago
Risk
CYTK
Cytokinetics announced expanded prescribing information for MYQORZO® (aficamten) incorporating Phase 3 MAPLE-HCM trial data, positioning the drug for a new heart-disease indication (Globe Newswire, 2026-11-16). Despite the clinical milestone, CYTK declined 4.40% to $53.66 intraday from $56.13. Trading volume stands at 0.50x the time-adjusted average, suggesting light participation.
2d ago
Valuation
ALB
Albemarle fell 4.12% to $89.68, hitting a new 52-week low, driven by a combination of soft lithium market pricing and recent analyst price-target cuts from major firms including Morgan Stanley, Bank of America, Deutsche Bank, and UBS. The decline reflects caution over near-term demand visibility and sequential deceleration expected in Q4 due to higher-cost inventory drawdown, despite ALB's Q3 earnings beat in early November.
2d ago
Valuation
ASTS
AST SpaceMobile fell 7.64% to $30.11, driven by a combination of broader space-sector weakness—with peers Rocket Lab and Firefly also declining—and pre-conference caution ahead of an investor conference starting November 17 where the market expects concrete updates on commercial service timelines and the Rakuten venture (Benzinga). Volume reached 5.58M shares, 1.29x the intraday average, signaling elevated trading activity.
2d ago
Valuation
GAP
Gap Inc. declined 5.53% to $19.91 as investors positioned defensively ahead of Q3 earnings scheduled for November 19, 2026 (after market close Thursday). The pullback reflects caution around holiday demand, Athleta's performance, and Old Navy's recovery trajectory, compounded by a recent Wells Fargo price target cut. Volume at 1.17x normal levels suggests orderly, anticipatory selling rather than panic.
2d ago
Valuation
CGON
CG Oncology announced positive Phase 3 PIVOT-006 trial results for cretostimogene in intermediate-risk and high-grade Ta non-muscle-invasive bladder cancer, with the company stating it is the first therapeutic to demonstrate significant recurrence benefit in this patient population (web catalyst). Stock surged +14.35% to $85.08 on 7.22x elevated volume, with the data triggering plans for two BLA filings in 2027.
2d ago
Valuation
SMCI
SMCI fell 4.91% to $25.55 on November 16, 2026, driven primarily by ongoing fallout from a reported Department of Justice smuggling investigation into whether entities tied to a former Megaspeed International executive helped smuggle Super Micro servers into China, compounded by sector-wide pressure on AI hardware makers. The stock has now declined 16.46% since November 2. Volume of 15.6 million shares was 0.85x the adjusted historical average at 150 minutes into the session.
2d ago
Valuation
SMMT
Summit Therapeutics received a Complete Response Letter (CRL) from the FDA for ivonescimab, its lead lung cancer drug, due to the absence of a statistically significant overall survival benefit in the HARMONi study—blocking the company's path to approval in its current form (Barron's, Benzinga). The stock plunged 15.34% to $11.98, with volume at 5.55x the expected level for this time of trading session, reflecting the market's immediate reaction to the regulatory setback for SMMT's flagship asset.
2d ago
Risk
COIN
Bitcoin selloff deepening, combined with institutional investor rebalancing. Per 247wallst.com, a broad crypto strategy declined 8% as Bitcoin weakness accelerated, pulling Coinbase down 7% alongside Microstrategy (MARA). Additionally, defenseworld.net reported that Eurizon Capital SGR reduced its COIN holdings. Stock fell 7.92% from $127.65 to $117.54 intraday.
2d ago
Risk
MSTR
Strategy Inc (MSTR) fell 8.67% to $101.94 as Bitcoin declined to $64,000 and the company faces a potential exit from the MSCI index, according to Benzinga. The stock has tracked Bitcoin volatility closely given Strategy's large digital-asset holdings.
2d ago
Valuation
NTRA
Natera shares fell 6.83% to $297.29 following a stock sale by Eurizon Capital SGR S.p.A., as reported by defenseworld.net. The decline occurred on volume of 591,699 shares (1.10x normal for this time of session), suggesting investor repositioning rather than broad selling pressure.
2d ago
Activity
TSN
Tyson Foods released fourth-quarter and fiscal 2026 financial results (Globe Newswire), missing earnings estimates per Zacks while guiding for a sales decline as the beef business remains under pressure (WSJ). Despite the miss and negative guidance, TSN surged +8.48% from $58.82 to $63.81 intraday—a counterintuitive rally that suggests market sentiment may be pivoting to relative relief or a valuation reset after prior weakness.
2d ago
Material / Earnings
FRMI
Fermi Inc. (FRMI) moved +25.18% from $2.08 to $2.61 on 2026-11-13 after announcing a 600 megawatt power capacity deal with an unnamed investment-grade hyperscaler for its Project Matador site in Texas, which includes a $200 million prepayment and $15 million early construction agreement, with first power delivery targeted for 2027. The company also terminated its TensorWave data-center lease in connection with the new partnership.
5d ago
Valuation
SMMT
Summit Therapeutics fell 6.03% to $14.17 on pre-catalyst de-risking ahead of an imminent FDA decision on ivonescimab for lung cancer, scheduled for November 14, 2026 (per web search and Yahoo Finance). Institutional investors are reducing exposure before the binary regulatory event despite the drug showing progression-free survival benefits in trials; uncertainty around overall survival data and Western-specific requirements is tempering confidence.
5d ago
Risk
RGTI
Rigetti dropped 7.07% to $9.60 as quantum computing stocks broadly sold off following sector headwinds. IonQ fell 8% and D-Wave declined 4–5% on the same day (247wallst.com, 2026-11-13), with the group pressured by a recent CEO admission that quantum computing cannot yet demonstrate clear return on investment and widening Q3 losses at Rigetti despite revenue growth. Volume is running 1.09x normal for this time of session.
5d ago
Material / Earnings
CTVA
Corteva, Inc. (CTVA) reported EPS of −$0.04 vs. consensus estimate of $0.02 for Q3 FY2026, missing by 321.2%.
7d ago
Valuation
FRMI
Fermi Inc. shares surged 30.10% to $2.68 following announcement of a major hyperscaler deal for 600 megawatts of capacity at its Project Matador site in Texas, secured by a $200 million prepayment and $15 million early construction agreement, according to the web catalyst. The rally extends momentum from the prior session despite today's earnings report showing a wider-than-expected Q3 net loss of $141.6 million; volume of 57.1 million shares is running 1.99x the historical average for this point in the session.
5d ago
Valuation
MOD
Modine Manufacturing surged 28.41% to $136.25 following Bloomberg reports that Samsung Electronics is in discussions to acquire the data center cooling specialist in a deal valued around $5.6 billion. Samsung is seeking Modine as a strategic asset to strengthen its AI infrastructure footprint, where liquid and thermal cooling for high-density processors is a critical bottleneck. Volume spiked to 4.88M shares, 7.25x the time-adjusted average, reflecting elevated investor interest.
5d ago
Valuation
CBRS
Cerebras Systems surged 8.24% to $105.80 following a strong Q3 2026 earnings beat, raised full-year revenue guidance, and announcement of a new cloud infrastructure deal with Microsoft, per Reuters and Invezz. The AI chipmaker reported record Q3 GAAP revenue of $210.8M and posted its first quarterly adjusted profit as a public company, projecting annual revenue will triple in 2027.
5d ago
Material / Earnings
TWST
Twist Bioscience Corporation (TWST) moved +14.69% from $99.59 to $114.22 on 2026-11-12 after reporting Q4 FY2026 results. The company reported a loss of $0.32 per share, beating the consensus estimate of $0.39 by 17.33%, alongside Q4 revenue of $126.6 million (beating expectations of $123–124 million) and adjusted EBITDA turning positive at $2.2 million. Full-year revenue grew 22%, with Q4 revenue up 28% year-over-year.
6d ago
Material / Earnings
LGN
Legence Corp. Class A Common stock (LGN) reported EPS of $1.15 vs. consensus estimate of $0.57, beating consensus by 100.7% on 2026-11-12.
6d ago
Material / Earnings
ARWR
Arrowhead Pharmaceuticals, Inc. (ARWR) reported EPS of −$3.04 vs. consensus estimate of −$1.52, missing by 100.0% on 2026-11-12.
6d ago
Material / Earnings
GPN
Global Payments Inc. (GPN) moved -11.95% from $100.16 to $88.19 on 2026-11-12, with volume 2.9x the 5-day average. On the same day, GPN announced integration of Visa's IDX API into its AI authentication platform to reduce false declines and boost payment approvals.
6d ago
Material / Earnings
NVDA
NVIDIA Corporation (NVDA) moved +10.05% from $151.01 to $166.19 on 2026-11-12, rebounding from a sharp decline triggered by CEO Jensen Huang's resignation. Huang stepped down amid governance concerns and personal conduct allegations, with CFO Colette Kress assuming interim leadership. The rebound came as analyst downgrades (Cantor Fitzgerald cut price targets from $350 to $250) and broader market anxiety appeared to stabilize, though volume remained elevated at 2.1x the 5-day average.
6d ago
Material / Earnings
CRWV
CoreWeave, Inc. Class A Common Stock (CRWV) moved +11.21% on 2026-11-12, two days after reporting Q3 results on 2026-11-10. The company reported Q3 revenues surged 168% year-over-year and disclosed a $132.5B backlog, though it also noted a Texas data center moratorium delaying revenue on existing contracts. CRWV met its EPS estimate at –$1.27 vs. –$1.27 consensus (no surprise).
6d ago
Material / Earnings
DELL
Dell Technologies Inc. (DELL) moved +10.44% from $336.09 to $371.17 on 2026-11-12, following CoreWeave's better-than-expected Q3 results and raised guidance, which signaled increased AI spending demand. The move also reflected relief after Dell announced record AI orders and a massive backlog despite earlier sector headwinds.
6d ago
Material / Earnings
CBRS
Cerebras Systems Inc. (CBRS) reported EPS of −$0.67 vs. −$0.15 consensus estimate for Q3 FY2026, missing by 333.5% on November 12, 2026.
6d ago
Risk
IBRX
ImmunityBio announced findings from a national survey of military service members and veterans with non-muscle invasive bladder cancer, showing 53% were diagnosed at age 50 or younger and revealing barriers to care (Business Wire, 2026-11-11). The stock fell 6.17% to $6.26 on above-average volume (1.78x normal), though the survey is epidemiological rather than clinical trial data.
6d ago
Valuation
LQDA
Liquidia rallied 4.29% to $57.58 following a wave of analyst upgrades anchored by Raymond James' upgrade to Strong Buy with a $77 price target (raised from $53) and BTIG's hike to $87 (from $70), both citing robust Q3 results and resilient demand. Q3 revenues surged 314.9% year-over-year to $225.3M, driven by YUTREPIA pulmonary arterial hypertension drug sales of $222.7M, per Zacks earnings coverage. Volume of 523K shares remains below the 0.59x time-adjusted average.
6d ago
Risk
HWC
Hancock Whitney announced its acquisition of Trustmark Corporation via Business Wire and SEC 8-K filing today, triggering an 11.84% intraday decline from $72.38 to $63.81. Volume surged to 9.67x the time-adjusted historical average (1.43M shares in 70 minutes), reflecting heavy selling pressure on the deal news.
6d ago
Valuation
TWST
Twist Bioscience reported Q4 FY2026 revenue of $126.6 million, beating consensus estimates of $123–124 million, and achieved a profitability milestone with adjusted EBITDA of $2.2 million (per Business Wire and Zacks). However, management's initial fiscal 2027 guidance disappointed: organic growth projected at ~21% and AI drug discovery revenue at ~$100 million (~69% growth) fell short of prior "triple-digit order growth" expectations, and gross margin guidance of 52.5–53% trailed consensus. The stock fell 10.47% to $109.75 on elevated volume of 3.93x average, triggering a "sell the news" reaction despite the revenue beat.
6d ago
Valuation
SYM
Symbotic is trading down ~5.65% to $35.02 as investors weigh valuation and customer-concentration concerns following its expanded Walmart automation agreement, alongside cautious positioning ahead of its November 23 earnings report. While the multi-year ~$6 billion Walmart deal expands backlog, elevated forward multiples and heavy revenue dependence on a single customer are tempering enthusiasm. Recent analyst caution—including a Hold rating and $35 price target from Jefferies and a trimmed $43 target from Baird—has pressured near-term momentum.
6d ago
Risk
FPS
Forgent Power Solutions reported fiscal Q1 2027 results above the high end of guidance and raised full-year outlook, citing strong commercial and operational execution (Business Wire). Despite the positive earnings beat and raised outlook, FPS fell 6.23% intraday from $24.57 to $23.04 on elevated volume of 6.68M shares (2.33x expected for this stage of session), suggesting a sell-the-news reaction.
6d ago
Valuation
FRMI
Fermi announced a $200 million hyperscaler commitment for its Project Matador power development in Texas and terminated its TensorWave lease arrangement, per its Q3 2026 earnings report filed today and covered by Barron's. The stock surged 22.10% to $2.21 on volume of 47.6 million shares (5.86x normal for this time of day), despite a wider-than-expected Q3 net loss of $141.6 million (22¢/share vs. 8¢ consensus loss).
6d ago
Activity
BLTE
Belite Bio reported unaudited third-quarter 2026 financial results and provided a corporate update via Globe Newswire today, lifting the stock +6.84% to $166.60. Volume surged to 172,051 shares in the first 100 minutes, running 4.03x the historical average for this time of day, signaling strong investor interest in the earnings announcement.
6d ago
Material / Earnings
BLTE
Belite Bio, Inc (BLTE) reported EPS of −$0.60 vs. −$0.79 consensus estimate, beating expectations by 23.7%.
6d ago
Material / Earnings
FRMI
Fermi Inc. Common Stock (FRMI) reported EPS of −$0.22 vs. consensus estimate of −$0.04 for Q3 FY2026, missing by 463%.
6d ago
Valuation
SMCI
Super Micro Computer shares fell 12.68% to $26.57 on renewed concerns over potential China-related export-control violations and compliance issues with AI hardware diversion, per Benzinga reporting cited in market commentary. The decline coincides with broader tech-sector selling and profit-taking across Nasdaq peers. Volume surged to 47.3M shares, 3.37x the time-adjusted average, reflecting elevated institutional and retail exit activity.
6d ago
Risk
MSTR
Strategy (MSTR) fell 5.44% to $115.69 after MSCI confirmed the company's removal from its indexes, as reported by The Wall Street Journal and Benzinga. The exclusion threatens passive fund outflows given Strategy's status as the world's largest corporate Bitcoin holder. Volume of 12.9M shares ran at 1.01x the historical average for this time of session.
6d ago
Valuation
NVDA
NVIDIA CEO Jensen Huang resigned following board pressure amid reports of personal conduct issues, with interim replacement Colette Kress named to lead. The shock triggered a 5.69% intraday drop to $163.85 (down nearly 7% at the open per the web catalyst), with analyst downgrades—including Cantor Fitzgerald cutting price targets from $350 to $250—compounding the sell-off and threatening to shed hundreds of billions in market value.
6d ago
Activity
AVGO
Broadcom rallied 5.21% to $363.19 as investors rotated away from Nvidia toward rival chipmakers, according to Benzinga and Barron's reporting on Thursday. The move reflects broader semiconductor sector momentum tied to AI infrastructure spending, with Wall Street analysts having historically underestimated hyperscaler capex demand (Motley Fool).
6d ago
Valuation
CTVA
Corteva reported third-quarter earnings of $0.06 per share, missing consensus estimates of $0.10, and Q3 revenue of $1.59 billion below the $1.76–$1.77 billion expectation (Benzinga). Latin American organic sales plunged 31% due to severe headwinds in Brazil—elevated inventory, delayed farmer purchases, high interest rates, and tight farmer liquidity—while the company lowered full-year 2026 EBITDA guidance to approximately $1.1 billion amid pricing pressures and elevated R&D spending. CTVA fell 24.22% intraday from $12.14 to $9.20.
6d ago
Material / Earnings
CTVA
Corteva, Inc. (CTVA) reported EPS of $0.06 vs. $0.02 consensus estimate, beating by 231.9% on November 11, 2026.
7d ago
Activity
GLXY
Galaxy Digital rose 9.96% to $15.52 as AI stocks broadly rallied Wednesday, according to Benzinga. The move aligns with sector-wide strength in artificial intelligence equities, though no company-specific catalyst was identified today. Volume through the 350-minute mark stands at 6.5M shares, tracking at 0.78x the historical average for this time of session.
7d ago
Valuation
FRMI
Fermi Inc. surged +21.10% to $1.86, driven by continued market optimism following its recent credit support and lease agreement with AMD for its Project Matador AI site in Texas, according to the web catalyst. The move reflects rising institutional and insider attention on high-growth AI infrastructure plays, with trading volume running above average.
7d ago
Risk
TTEK
Tetra Tech shares fell 6.67% to $37.94 amid elevated trading volume of 4.6 million shares—3.04x the time-adjusted historical average—as the stock was flagged as a name to watch heading into Wednesday (Benzinga). The sharp intraday decline on heavy volume suggests institutional repositioning or a potential catalyst not yet reflected in available news.
7d ago
Valuation
FRVO
Fervo Energy (FRVO) jumped 15.11% to $13.10 following announcement that its Utah geothermal power plant achieved commercial operation for its first block, per Barron's. The facility is tied to a 396-megawatt Google supply agreement (Cape Station, expected 2028 completion). Q3 results—$116,000 revenue and $0.07 adjusted loss per share—beat consensus expectations. Volume at 8.4M shares (1.25x normal for this time of day) suggests broad participation in the move.
7d ago
Activity
MXL
MaxLinear announced Jeju™, a custom power management IC (PMIC) designed for next-generation 1.6T optical modules, delivering up to 95% efficiency to reduce power and thermal load in high-speed data center infrastructure (Business Wire, Nov 10). The stock rose 14.86% to $61.83 on moderate volume (0.90x average for the session elapsed).
7d ago
Valuation
FROG
JFrog reported Q3 2026 results beating consensus on both revenue ($179.2M vs. $165.9M expected) and non-GAAP EPS ($0.32 vs. $0.23 expected), with cloud revenue surging 60% year-over-year to $101.5M driven by AI-generated code governance demand. Management raised full-year 2026 revenue guidance to $680–$682M. The stock rose 8.27% to $112.11 on post-earnings momentum continuation, with volume at 1.02x normal for the session time.
7d ago
Activity
AAOI
Applied Optoelectronics surged 18.83% to $57.42, driven by a sector-wide rebound in AI-linked optical networking stocks following CoreWeave's strong Q3 earnings and upgraded full-year guidance (per web sources including finance.yahoo.com). AAOI itself reported record Q3 2026 revenue of $269.88 million (+127% YoY) and returned to GAAP profitability ($0.07 EPS), with Q4 guidance of $385–$420 million revenue backed by robust 800G and 1.6T data center demand. Volume of 9.71 million shares (1.19x historical average) reflects normal participation for this time of session.
7d ago
Valuation
DOCN
DigitalOcean rallied 11.02% to $88.28 as part of a broader technology sector rebound, fueled by strong Q3 2026 earnings released November 3 that beat on both revenue ($321M, +40% YoY) and EPS ($0.45 vs. $0.32 consensus), plus raised full-year 2027 guidance projecting 60%+ growth. Volume at 1.10x normal for this point in the session reflects elevated participation in the recovery.
7d ago
Valuation
AMKR
Amkor Technology surged +12.14% to $38.66 on a broad semiconductor sector rally driven by positive Wall Street credit research on AI data center funding. JPMorgan credit analysts reported that cloud provider CoreWeave is funding its expansion through customer prepayments and operating cash flow rather than new debt, easing investor concerns about stalled hardware delivery schedules and sustaining cloud capital spending that underpins chipmaker demand. Volume ran 1.30x expected, consistent with normal intraday activity at this session stage.
7d ago
Valuation
TLN
Talen Energy surged 6.03% to $382.97 following announcement of a 750 MW long-term capacity agreement from its Guernsey Power Station in Ohio, expected to generate ~$100M in annual revenue starting 2029–2030, combined with strong Q3 cash flow results and Morgan Stanley's price target increase to $512 with Overweight rating (Globe Newswire, Investing.com). Volume of 385k shares ran at 0.87x normal for this time of session.
7d ago
Activity
ENTG
Entegris filed a material event 8-K today, prompting a 6.11% intraday gain to $147.03. The specific details of the filing were not disclosed in available sources, but the market responded positively to the announcement. Volume remains near historical averages at 0.98x expected for this time of session.
7d ago
Valuation
RKLB
Rocket Lab reported record Q3 2026 revenue of $267.8 million (up 73% YoY, beating consensus ~$257–$258M) and record backlog of $3.57 billion (+52% sequentially), anchored by $1 billion in new launch contracts and 8 newly booked Neutron missions at $70 million per launch, per investors.rocketlabcorp.com. The stock rose 5.65% to $66.25 on strong investor reception to the results and upbeat Q4 guidance of $270–$290 million.
7d ago
Valuation
BE
Bloom Energy surged +9.28% to $202.63 amid a sector-wide artificial intelligence infrastructure rally, driven primarily by CoreWeave's stronger-than-expected Q3 earnings and raised full-year revenue guidance (Benzinga, Motley Fool). The gain reverses post-election anxiety over AI capex profitability and builds on BE's earlier announcement of a massive 1.6 GW fuel cell contract backlog.
7d ago
Valuation
LITE
Lumentum surged +13.31% to $663.50 as part of a broader rally in optical networking and AI infrastructure stocks, driven by strong momentum from peers like CoreWeave and Applied Optoelectronics amid renewed confidence in data center spending and AI hardware supply chains (Yahoo Finance, Investing.com). Volume reached 2.41M shares, 2.09x the time-adjusted average, signaling broad institutional participation in the sector recovery.
7d ago
Valuation
MPWR
Monolithic Power Systems (MPWR) surged +7.88% to $1,464.55, driven by a sector-wide semiconductor and tech rebound combined with sustained momentum from the company's late-October Q3 2026 earnings report, which showed record revenue of $1.2 billion (+63% YoY) and raised enterprise data growth guidance to 150% (per web catalyst). Technical breakouts above the 20-day, 50-day, and 200-day moving averages have triggered additional buying pressure. Volume of 233,195 shares is normal for this stage of the trading session.
7d ago
Valuation
DELL
Dell Technologies surged +8.57% to $363.03 on November 11 as the company announced multiple product and partnership wins: a collaboration with KIOXIA on an industry-first 157 PB single-rack object store, a University of Alabama HPC deployment, and updates to its AI Data Platform and storage offerings (PowerScale and ObjectScale integrated with NVIDIA systems). According to Benzinga, the move also reflected a broader market bounce after a recent multi-day tech sector pullback, with investors citing Dell's multi-billion-dollar AI server backlog and strong customer demand as fundamental support.
7d ago
Activity
MRVL
Marvell Technology surged +10.17% to $170.09, reversing recent weakness. Trading volume reached 11.9M shares (2.01x the time-adjusted average), signaling strong intraday buying interest. Coverage from Invezz and Motley Fool cited the move as either a potential recovery or buying opportunity following the stock's recent decline, though no specific company-reported catalyst or market event was disclosed in available reports.
7d ago
Valuation
SNDK
SanDisk surged +16.68% to $1,003.41 following sector-wide momentum in memory stocks, driven by Morgan Stanley's upgraded outlook on the memory sub-sector and strong CoreWeave earnings that reinforced AI infrastructure demand (Barron's, invezz.com). Volume spiked to 2.92x the time-adjusted average at 7.46M shares, reflecting broad institutional and retail participation in the memory rally.
7d ago
Valuation
MRCY
Mercury Systems beat fiscal Q1 2027 earnings expectations with non-GAAP EPS of $0.52 (vs. $0.30 consensus), revenue of $253.0M (+12.4% YoY, beating $245.0M estimate), and record quarterly bookings of $370M (+48% YoY), driving a 1.46 book-to-bill ratio and $2.1B total backlog. Management raised full-year 2027 guidance targeting ~$210M adjusted EBITDA and ~40% free cash flow conversion, prompting J.P. Morgan to upgrade the stock and Piper Sandler to reiterate Overweight with a $107 price target. Stock up 4.56% to $87.39 on 860K shares (1.81x normal volume).
7d ago
Valuation
LQDA
Raymond James upgraded Liquidia to Strong Buy and raised its price target from $53 to $77 per share, driving a third consecutive day of gains. The stock climbed 8.07% to $55.55, breaking above its 50-day moving average following today's earnings report and an SEC 8-K filing. Volume of 2.19M shares is running at 0.76x the typical level for this point in the session.
7d ago
Valuation
MU
Micron rallied 9.99% to $797.57, driven by multiple AI-sector tailwinds: Anthropic's updated IPO filing revealed Micron among major buyers in a $26 billion private placement (per web synthesis), CoreWeave raised its 2026 revenue guidance to $13.0–$13.3 billion signaling robust data-center demand, and tighter DRAM supplies amid disciplined capex are lifting earnings projections. Semiconductor peers Seagate and SanDisk also spiked 8–9% on the same catalysts, reflecting sector-wide momentum recovery post-election sell-off.
7d ago
Valuation
CRWV
CoreWeave surged 21.75% to $59.33 after posting better-than-expected Q3 earnings and raising full-year 2026 revenue guidance, per the web catalyst. CEO Michael Intrator also addressed financing concerns by shifting toward customer-contract-backed facilities instead of unsecured public debt, easing investor worries about borrowing costs in the AI infrastructure sector. Volume hit 70.6M shares (5.75x historical average at this session time), reflecting broad appetite for the AI compute narrative.
7d ago
Stocks tracked
986
Total changes
47087
Most active
MU
Avg 30D change
-0.08%

Educational research tool — not personalized investment advice. Data may be delayed.